MicroGEM

MicroGEM democratizes molecular biology by moving molecular technologies from traditional high-skill labs to non-laboratory settings, enabling their use when needed to solve complex biological problems. The company’s innovative enzymatic approach to nucleic acid extraction lays the foundation for rapid sample preparation suitable for PCR analysis. Combined with MicroGEM’s expertise in microfluidics and synthetic biology, the company is in a strong position to create personal portable diagnostic devices, representing the next generation of rapid, point-of-care solutions that can address global health challenges.MicroGEM’s COVID-19 saliva test provides lab-quality results in 15 minutes, allowing non-medical personnel to quickly and on-site detect COVID-19 without a laboratory.